Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
MORTIMER IAN
PRESIDENT & CEO at Xenon Pharmaceuticals. Filing since 24 Jun 2016.
CIK 0001619961
Company
Date
Role
Action
Shares
Amount
Of holding
XENE
Xenon Pharmaceuticals Inc.
30 Sep 2026
PRESIDENT & CEO
Bought
30,000
$1.12M
151%
XENE
Xenon Pharmaceuticals Inc.
13 Mar 2026
PRESIDENT & CEO
Sold on a plan
7,308
$403.58K
26.8%
XENE
Xenon Pharmaceuticals Inc.
10 Mar 2026
PRESIDENT & CEO
Sold on a plan
11,269
$677.36K
43.3%
XENE
Xenon Pharmaceuticals Inc.
9 Mar 2026
PRESIDENT & CEO
Sold on a plan
270,000
$16.29M
97.8%
XENE
Xenon Pharmaceuticals Inc.
2 Jan 2026
PRESIDENT & CEO
Sold on a plan
40,000
$1.78M
87.0%
XENE
Xenon Pharmaceuticals Inc.
8 Dec 2025
PRESIDENT & CEO
Sold on a plan
10,830
$495.21K
64.3%
XENE
Xenon Pharmaceuticals Inc.
5 Dec 2025
PRESIDENT & CEO
Sold on a plan
14,375
$647.31K
46.1%
XENE
Xenon Pharmaceuticals Inc.
28 Nov 2025
PRESIDENT & CEO
Sold on a plan
97
$4.37K
0.3%
XENE
Xenon Pharmaceuticals Inc.
1 Oct 2025
PRESIDENT, CEO & INTERIM CFO
Sold on a plan
25,000
$1.00M
44.4%
XENE
Xenon Pharmaceuticals Inc.
27 Jan 2025
PRESIDENT & CEO
Sold on a plan
16,315
$660.81K
34.3%
XENE
Xenon Pharmaceuticals Inc.
24 Jan 2025
PRESIDENT & CEO
Sold on a plan
22,468
$903.21K
41.8%
XENE
Xenon Pharmaceuticals Inc.
23 Jan 2025
PRESIDENT & CEO
Sold on a plan
16,217
$649.98K
34.1%
XENE
Xenon Pharmaceuticals Inc.
24 May 2023
PRESIDENT & CEO
Sold at will
31,655
$1.31M
56.7%
XENE
Xenon Pharmaceuticals Inc.
10 Aug 2017
CFO & COO
Bought
10,000
$29.00K
233%
XENE
Xenon Pharmaceuticals Inc.
10 Aug 2017
CFO & COO
Bought
5,000
$14.23K
500%
XENE
Xenon Pharmaceuticals Inc.
24 Jun 2016
CFO & COO
Bought
4,300
$26.79K
opened
XENE
Xenon Pharmaceuticals Inc.
24 Jun 2016
CFO & COO
Bought
1,000
$6.15K
opened
17 decisions on file.
